New analysis

Us Bancorp USB

Super-regional bank priced for permanent stagnation; cheap if discipline returns.
12-year-old test
U.S. Bancorp is a big regional bank. It takes in money from people's checking accounts (cheap), lends that money to businesses and homeowners (more expensive), and keeps the difference. It also runs a payments business that helps stores accept credit cards. Right now the stock is on sale because everyone is scared regional banks are unsafe after some failed in 2023. The math says it's worth almost twice today's price if it works out normally. But banks are tricky — they make money by taking small risks with borrowed money, and sometimes the risks come back to bite.
Composite Score
69
/ 100
Above median
Recommendation
Buy
Add only below $58
Trim above $135.
Intrinsic Value (Base)
$57 · $100 · $150
Px $53 · 44% below IV (margin of safety)

Quantitative scorecard

/100 · weighted equally across four pillars
Profitability quality
11/25
ROIC 10y avg0.0%
ROIIC 5y
FCF / NI (5y)0.0%
Gross margin trendflat
Op-margin stability
Balance sheet
17/25
Net debt / EBITDA
Interest coverage
Current ratio
Goodwill / equity19.4%
Off-balanceClean
Capital allocation
20/25
Share count Δ 10y-1.1%
Buyback timingMixed
Dividend payout49.1%
M&A track recordOrganic
CEO communicationDefault
Valuation
21/25
P/E vs 10y avg1.08x
EV/FCF vs 10y avg
Reverse-DCF growth-0.6%
Px / Base IV0.56x
Margin of safetyPresent
Owner Earnings (TTM)
USD
Net income (TTM)$6.30B
+ Depreciation & amortization+ derived
+ Stock-based compensation+ derived
− Maintenance capexmedian of Greenwald / D&A / capex-rev− $-InfinityB
− Δ Working capital− derived
= Owner Earnings$6.30B
For comparison: GAAP FCF (TTM)$0.00

Thesis

U.S. Bancorp is the fifth-largest U.S. commercial bank by assets, a deposit-funded lender and payments processor that for two decades was the standout efficiency-ratio name in American banking. It earns money the old-fashioned way: cheap funding from sticky retail and commercial deposits, spread against a diversified loan book (commercial, CRE, residential mortgage, credit card, other retail) and supplemented by genuinely high-margin fee businesses (Elavon merchant acquiring, corporate trust, payment services).

The scorecard tells a tension-filled story. Owner earnings TTM are $6.299B and the share count has shrunk 1.1% over ten years — modest but real per-share progress. P/E TTM of 14.85 is near the 10-year average of 13.79, so this is not a multiple-compression story; it is an earnings-power story. The reverse-DCF implies -0.58% growth in perpetuity, which is the market betting that the post-Union Bank integration, the post-2023 regional-bank-crisis deposit cost shock, and the looming Basel III endgame have permanently broken the franchise.

The IV math is the punchline: low $56.72, base $99.95, high $149.96, current $56.30. The market is paying the bear case in full and giving you a free option on mean reversion. The composite score of 69 (profitability 11, balance sheet 17, capital alloc 20, valuation 21) reflects a cheap-but-ordinary bank, not a wonderful one. ROIC isn't meaningful for a deposit-taker, so the scorer leaves it at 0.0 and we lean on owner earnings and per-share metrics instead.

At $56.30 against IV-low of $56.72, the margin of safety is mathematical even on the bear case. You are buying USB at trough sentiment, trough multiple, and trough returns on tangible equity. If management's stated 17%+ ROTCE target is achievable in a normalized rate environment, IV-base of ~$100 is the right anchor and this is a Buy.

Moat

U.S. Bancorp's moat is the classic super-regional bank stack: low-cost deposit funding, scale-driven cost advantages, switching costs in primary checking and commercial treasury relationships, and intangibles in the form of the U.S. Bank brand and fifty-state charter. Buffett's framework for understanding capital-intensive regulated businesses applies here in spirit — a bank's deposit franchise is, like a regulated utility, an essential-service business funded by liabilities the customer is reluctant to move [3][6]. But banking is more cyclical, more leveraged, and less protected than rails or utilities, and the moat is narrower than bulls claim.

Cost advantages (the strongest claim). USB historically ran one of the best efficiency ratios among the top-10 U.S. banks (high-50s%), reflecting genuine scale economies in branch infrastructure, technology, and back-office processing. Its Elavon merchant-acquiring business is a top-five U.S. acquirer with global presence, and its Corporate Trust business is a top-three player with very high incremental margins. These are scale businesses where the marginal customer adds revenue without proportional cost. Verdict: real but eroding. Post-Union Bank integration costs and the 2023 deposit-repricing shock have compressed the efficiency advantage to merely competitive.

Switching costs (medium). Primary checking accounts are notoriously sticky — direct deposits, autopay, bill-pay history — and commercial treasury management relationships are even stickier (ACH origination, lockbox, integrated ERP feeds). However, the 2023 regional-bank crisis demonstrated that uninsured commercial deposits will move at the speed of a Bloomberg terminal when fear arrives. Switching costs are real for retail, weaker than assumed for jumbo commercial deposits.

Network effects (limited). Visa/Mastercard own the four-party network; USB participates as an issuer and acquirer. Elavon has some two-sided dynamics (more merchants -> more issuer relevance) but operates inside the card network, not as one. Not a true network-effect business.

Intangibles (weak-to-medium). The U.S. Bank brand has trust value, but commodity banking offers little pricing power. Regulatory licenses (50-state bank charter, OCC primary regulator status as a Category III GSIB-adjacent institution) are barriers to entry — you cannot start a new top-10 bank — but they also impose Basel III endgame capital requirements that compress ROTCE.

Pricing power (none). Deposit pricing is set by Fed funds plus a spread the customer dictates; loan pricing is set by competition with money-center banks, regionals, and increasingly private credit. USB cannot raise prices on a checking account or a C&I loan without losing the customer. This is the fundamental reason the scorer's profitability score is 11/30 — banks compete on cost and risk discipline, not pricing.

Competitor stress test ($10B + 5 years). Could a competitor with $10B and five years build USB? No — you cannot buy a deposit franchise of $500B+. But could a JPMorgan with its $4 trillion balance sheet take incremental share from USB in commercial banking and payments? Absolutely, and they are. Could Chime, Cash App, and the neobanks erode the retail deposit base? They already have, at the margin, with younger demographics. The moat is durable against new entrants but porous against larger and more digital incumbents.

Erosion risk. Three vectors: (1) Basel III endgame capital requirements push ROTCE structurally lower; (2) deposit beta in the next cycle is permanently higher because customers learned in 2023 that uninsured deposits aren't safe; (3) JPMorgan's tech spend ($17B/year) means scale is moving up-market faster than USB can match.

Buffett's own canon is instructive here: he praises BNSF and MidAmerican because their interest coverage is 9-10x and their earnings are essential-service stable [1][3]. A bank's interest expense IS its cost of goods sold, and its coverage ratio is structurally lower and more volatile. USB is not BNSF.

Moat verdict: NARROW.

L
Learning Note
Moat durability — the Munger filter
The test: if a well-funded competitor had $10B and 5 years, could they meaningfully damage this business? If yes, the moat is narrower than it looks.
Used in Step 5 — Moat Assessment

Management & Capital Allocation

Capital allocation at U.S. Bancorp must be evaluated against the five-choice framework — reinvest, acquire, debt, buybacks, dividends — and the news here is mixed.

Reinvestment. Banks reinvest by growing the loan book and the deposit franchise. USB has reinvested into payments technology (talech acquisition, State Farm credit-card portfolio), digital banking platforms, and the Union Bank franchise on the West Coast. The MUFG Union Bank acquisition closed in December 2022 for $8.0B and added ~$58B of deposits and ~$58B of assets, materially deepening the California presence. Whether this was a good deal is the central management question of the past three years. It was completed at the absolute worst time — just before the Fed's most aggressive hiking cycle in 40 years and the March 2023 regional-bank crisis. Integration ran over budget, the locked-in low-yield securities portfolio bled mark-to-market value, and the deal's promised accretion has been pushed out repeatedly.

Acquisitions. Pre-Union Bank, USB's M&A track record was disciplined and bolt-on (Elavon, talech, the State Farm card book). Union Bank was the largest acquisition in company history and, in retrospect, looks like a top-of-cycle deal. CEO Andy Cecere staked his tenure on it. The fairest read: a strategically sound deal executed at a strategically terrible price. Buffett's canon warns against this: he praises BNSF as bought 'amidst the gloom of the Great Recession' [4] — Union Bank was bought amidst the euphoria of 2021.

Debt. USB carries the debt structure required by Basel III and by GSIB-adjacent regulation (TLAC, long-term debt rule). This is not optional; it is regulatorily mandated. The balance-sheet score of 17/25 reflects adequate but not fortress capitalization. Buffett's standard — interest coverage ample under terrible conditions [1][3][6] — does not translate cleanly to a bank, where interest expense is cost of goods sold rather than financing cost. CET1 ratio is the relevant gauge; USB sits in the middle of the super-regional pack at ~10.8%.

Buybacks. Share count is down 1.1% over ten years per the scorecard. This is genuinely modest. USB has paused and restarted buybacks repeatedly, most recently pausing through the Union Bank integration and the AOCI rebuilding period. There is no public disclosure of a P/IV discipline, and given that the stock has spent significant time below tangible book value over the past three years, management arguably should have been buying aggressively. They were not — capital was conserved for regulatory cushion. Defensible, but not opportunistic in the Buffett sense.

Dividends. USB has paid an uninterrupted quarterly dividend for more than 150 years and has a strong record of annual increases. Current yield is in the 4%+ range. The dividend is well-covered by core earnings but consumes a large fraction of distributable capital, leaving less for buybacks. This is a yield-stock posture, not a compounder posture.

Communication quality. Cecere's investor communications are competent, on-message, and free of obvious puffery. The 10-Ks and proxies are dense but transparent. There has been no major restatement, no SEC enforcement action, no whistleblower scandal. However, the messaging around the Union Bank deal accretion has shifted multiple times, and the timing of efficiency-ratio targets has slipped. This is honest under-promising's opposite — over-promising followed by walking back.

Insider behavior. Insider ownership is low (sub-1% combined), as is typical for a regulated bank where outsized equity stakes raise governance flags. Insider buying has been modest, not the 'big swing' you would expect if management saw the IV gap the scorecard implies.

Synthesis. This is a B-grade allocator: disciplined dividend, decent operational reinvestment, modest buybacks, one large acquisition that was strategically right and tactically expensive. They did not blow up the franchise. They also did not compound shareholder value at a rate that distinguishes them from peers. In a sector where the difference between a great allocator (Jamie Dimon at JPM) and a poor one (countless regional CEOs over the past 20 years) is an order of magnitude in terminal value, USB management is solidly average.

Capital allocator: B.

Industry Structure

U.S. commercial banking is a regulated oligopoly with structurally mediocre economics for sub-money-center participants. Porter's Five Forces:

Threat of new entrants — LOW. A new top-10 U.S. bank cannot be created. Regulatory barriers (OCC chartering, Federal Reserve supervision, FDIC insurance qualification, state-by-state branch licensing, Basel III capital floors) are prohibitive. Even the well-capitalized neobanks (Chime, SoFi, Cash App banking) operate on partner-bank rails and have not penetrated the core commercial banking and treasury management franchise. This is the strongest force in USB's favor.

Bargaining power of buyers — MODERATE-TO-HIGH and rising. Retail depositors historically had low power because of inertia and switching cost; the 2023 regional-bank crisis and the rise of high-yield online savings accounts (Marcus, Apple Card Savings, brokerage sweep programs) have permanently raised the floor on deposit pricing. Commercial customers, especially treasury-management clients above $5M deposits, can move with a few keystrokes — and did, in March 2023. The era of 'free' deposits is structurally over for the next decade. This is the most negative force for USB's earnings power.

Bargaining power of suppliers — MODERATE. Banks' 'suppliers' are depositors (covered above) and the technology stack (FIS, Fiserv, Jack Henry for core systems; Visa/Mastercard for card rails; Microsoft/AWS for cloud). USB has scale leverage with the core processors but is a price-taker on Visa/Mastercard interchange and on cloud infrastructure. Tech vendor consolidation has not been kind to bank margins.

Threat of substitutes — HIGH and rising. Private credit has taken roughly $1.5T of middle-market lending share from banks over the past decade — direct lending funds (Apollo, Ares, Blackstone Credit, Blue Owl) outcompete on speed, covenant flexibility, and willingness to hold floating-rate paper that banks cannot under Basel III. In payments, Stripe and Adyen have eroded merchant-acquiring economics for Elavon. In retail savings, Treasury direct and money market funds yield 4%+ when bank deposits yield 0.1%. The substitution pressure is structural and persistent.

Rivalry among existing competitors — HIGH. The U.S. has ~4,500 commercial banks, the most fragmented developed-market banking system in the world. JPMorgan, Bank of America, Citi, and Wells Fargo (the Big Four) have scale advantages in technology and capital markets that USB cannot match. The other super-regionals (Truist, PNC, Capital One/Discover, Citizens, Fifth Third, Huntington, Regions, KeyCorp, M&T) compete for the same middle-market commercial customer. Pricing discipline holds in good times and breaks in cycles. Competitive intensity is permanent.

Value pool location and trajectory. The industry value pool has been migrating away from net-interest-income (commodity, regulated, capital-intensive) toward fee businesses (asset management, payments, advisory, insurance brokerage). USB has more fee-business exposure than most peers (Elavon, Corporate Trust, payments services represent ~40% of revenue), which is the bull case. But each of those fee pools is also under attack: payments from fintech, corporate trust from low-fee passive managers, advisory from larger competitors. The value pool is shrinking for net interest income and getting more contested in fees.

Trajectory. Basel III endgame, finalized in 2024-2025 in a watered-down form, still raises capital requirements for Category III banks like USB by 5-10% on a pro-forma basis. Higher capital requirements mean lower ROTCE for the same business, mechanically. The industry is slowly, structurally, moving toward lower returns on equity.

Industry Verdict: Average.

Mandatory Inversion
Inversion: the analysis below is intentionally adversarial. It is the strongest credible bear case, written without deference to the bull thesis. Weight it equally.

Inversion (Bear Case)

I am the short-seller. My job is to tell you why USB at $56.30 is going to $30, not $100.

The single event that kills this. A second regional-banking crisis — triggered by commercial real-estate losses, a large single-name credit blowup (Charter, a major REIT, a private-credit-funded LBO that goes bad), or a step-function repricing of multifamily and office loans — drives a deposit run on the super-regionals. USB's CRE book is meaningful; office-related exposure is non-trivial; the AOCI hole on the held-to-maturity securities portfolio remains open. A single quarter of accelerated NCOs in CRE plus a 50bps deposit beta surprise plus a pause in buybacks plus a dividend cut signal collapses the equity story. The stock goes from 'cheap regional bank' to 'broken regional bank' overnight, and the multiple goes from 14x to 8x on top of an earnings cut from $4 to $2.50. That puts the stock at $20.

Why the moat is narrower than bulls think. The bull case rests on three pillars: low-cost deposit funding, sticky commercial relationships, and high-margin fee businesses. All three are eroding. Deposits: brokerage sweep yields and Treasury Direct have permanently raised the cost of retail deposits; the era of 0.05% checking accounts funding 5% loans is over. Sticky commercial: 2023 proved that the assumption of stickiness was always wrong — modern treasury management software allows a CFO to move $500M in 90 seconds. Fee businesses: Elavon is losing share to Stripe and Adyen at the high end and Square at the low end; Corporate Trust is in secular decline as bond issuance shifts to passive vehicles; payments interchange is under regulatory attack via the Credit Card Competition Act. Each individual erosion is gradual; together they compound to a 200-300bps efficiency-ratio degradation over five years that the bull model does not contemplate.

Why management is worse than it appears. Andy Cecere bet his tenure on Union Bank at the worst possible moment. The fact that he survived the 2023 regional-bank crisis is a low bar. The repeated walking-back of efficiency-ratio targets and Union Bank accretion timelines is a pattern, not an accident. Insider buying has been minimal — if management saw the IV gap the scorecard implies, the C-suite would be buying aggressively at the personal-account level. They are not. The board approved a $5B buyback authorization in 2022 and used it sparingly when the stock was at $35; that is a material capital-allocation failure that is rarely discussed. The dividend is sacred at USB, which means in a stress scenario, capital is preserved for the dividend rather than used opportunistically — exactly the wrong allocation priority for a long-term compounder. This is not a Buffett-quality allocator; it is a yield-utility allocator.

What bulls are extrapolating that won't hold. The bull case extrapolates a return to 17%+ ROTCE, a 56% efficiency ratio, and 6-8% earnings growth. None of those is achievable in the post-Basel-III-endgame regime. ROTCE structurally settles at 12-14%. Efficiency ratio settles in the low 60s%, not the mid-50s%. Earnings growth, after share-count reduction, is 3-4% real, not 6-8%. The reverse-DCF of -0.58% is closer to right than the bull model's +6%. Furthermore, the bull case assumes the IV calculation of $99.95 is anchored on owner earnings of $6.299B that will grow; if those earnings shrink under deposit-beta and capital pressure, IV-base re-rates to $70-75, which is barely above today's price.

Valuation trap. USB has traded at a P/E of 13-15x for fifteen years. There is no historical precedent for it re-rating to 18x. The catalyst people imagine — Fed cuts, deposit costs normalize, NIM expands, ROTCE recovers — is not catalysts; it is a return to cycle-average that is already in consensus estimates. Meanwhile, the multiple-compression case is real: if the market decides super-regionals deserve 10x earnings (because they are growth-less, capital-intensive, regulated utilities without the regulated returns of a real utility), then EPS of $4 times 10x equals $40, even with no fundamental deterioration. The valuation trap is not 'cheap stock gets cheaper because of bad news'; it is 'cheap stock gets cheaper because the multiple was always wrong.'

Bear-case math. Earnings of $3.75 (a moderate compression from $4 normalized) times a 10x re-rated multiple equals $37.50. In a stress scenario with credit losses, $2.50 times 8x equals $20. Even the muddle-through case — earnings flat at $4 with a 12x multiple — gives $48, below today's price.

If I am right, the stock could be worth $35 within 3 years.

Lollapalooza Bias Check

Several biases are active in me as I write this analysis, and I should name them before they corrupt the recommendation.

Anchoring (high). The IV-base of $99.95 is a powerful anchor. The moment I see a stock at $56 with 'fair value $100,' my brain pattern-matches to 'undervalued, buy.' But the IV calculation is itself a function of growth and discount-rate assumptions; if owner earnings deteriorate or the regime shifts, IV-base falls. I should not treat $99.95 as a fixed point in space.

Authority bias (medium). Buffett owned USB for years and only fully exited in 2022. The fact that 'Buffett liked this' creates a halo. But Buffett also exited Wells Fargo and the airlines, and his exit from USB is itself information — he saw the regulatory and competitive trajectory and decided his capital had better uses. I should weight his exit, not his prior ownership.

Recency bias (medium-high). I am writing in May 2026 with the 2023 regional-bank crisis still vivid. I am almost certainly over-weighting the probability of another deposit-run scenario. I tried to acknowledge this in the bull case (lens 2) but the residual fear may still be biasing me toward a conviction lower than the math justifies.

Confirmation bias (medium). I came into this analysis with a working hypothesis of 'cheap regional bank, decent buy.' I notice I am reaching for evidence that supports the buy thesis (the IV gap, the 150-year dividend record, the diversified fee businesses) and am working harder to construct the bear case. The mandatory inversion section was specifically designed to fight this bias; I should re-read it and ask whether I genuinely believe the $35 target or whether I dismissed it because I prefer the buy conclusion.

Social proof (low-medium). USB is a consensus 'cheap regional bank' name in value-investor circles. Many newsletters and podcasts have flagged it as a buy. This is a weak form of social proof — the fact that other value investors agree with my conclusion does not make it more likely to be right; it may simply mean we share the same bias.

Commitment / consistency (low). I have no prior position in USB and no public statement about it. This bias is mostly inactive.

Deprival super-reaction (low). I am not currently long USB, so I am not vulnerable to the 'don't take my paper gain away' version of this bias.

Incentive bias (medium, structural). The Compounder framework rewards finding wonderful businesses at fair prices. There is implicit pressure to come back with a recommendation, and 'Hold' or 'Too Hard' feels like a non-answer. I should resist the pressure to manufacture conviction.

Lollapalooza synthesis: Anchoring + authority + confirmation + a mild incentive bias are all pulling me toward Buy with high conviction. The mandatory inversion and the recency check pull the other way. The honest position is Buy with medium (not high) conviction, sized smaller than the IV gap alone would suggest.

10-Year Outlook

Ten-year outlook test:

Same fundamental business model? Yes, with caveats. USB will still be a deposit-funded commercial bank, still run Elavon, still operate corporate trust and payment services, still issue credit cards. The economic shape of the business — gather deposits cheaply, lend prudently, harvest fees from payment rails — will be recognizable. But the proportions will shift: less net-interest-income share, more fee-business share, lower leverage, higher technology costs.

Customer base larger? Modestly. Population grows ~0.5%/year. USB's branch footprint is mature; the post-Union-Bank California expansion is the last big geographic move. Customer growth will come from digital acquisition (low-margin, high-CAC) and small-business banking. Realistic ten-year customer growth: 10-15% total, not the 30%+ that would justify a growth multiple.

Profit per customer higher? Probably flat-to-modestly-up. Deposit-pricing pressure offsets fee-business growth. Basel III endgame caps the leverage multiplier. Net: profit per customer in real terms is approximately flat over a decade.

Moat wider? Likely narrower. Fintech substitution (in deposits, payments, and lending) compounds slowly but persistently. JPMorgan's technology spend widens the gap with super-regionals each year. The CRA of large universal banks improves; USB's relative position erodes.

Single biggest threat. A combination of CRE losses and Basel III capital requirements forcing a structural ROTCE reset to 11-12%, which would compress IV-base by 25-30% from current $99.95 to $70-75. This is the threat I weight most heavily.

Best-case threat. Private-credit competition continues taking middle-market lending share, eroding USB's most profitable loan book. This is gradual but cumulative — five points of market share loss over ten years compounds to meaningful earnings deterioration.

What gets better. Scale economics in technology if USB partners or consolidates with a peer (M&T, KeyCorp, Fifth Third). Regulatory cycle eventually loosens (post-2030, plausibly). Demographic tailwind in retirement-age customer cohort favors trusted incumbent banks over neobanks.

Net assessment. USB will exist and be profitable in 2036. It will not be a wonderful business. It will be a fair business with a reliable dividend, modest buybacks, and earnings power that grows roughly with nominal GDP. The moat is real but narrowing. The 10-year outlook is a muddle-through with optionality on regime change in either direction.

CONFIDENCE: medium

Position guidance

- **Recommendation:** Buy
- **Conviction:** Medium
- **Target buy price:** $58 (near IV-low of $56.72; current $56.30 already qualifies)
- **Target trim price:** $135 (near IV-high of $149.96, trim aggressively above $120)
- **Position sizing:** 2-3% portfolio weight. This is a cheap-but-not-wonderful business; size for the IV gap, not for compounding quality. Add on weakness below $52, trim above $90, exit above $130.
- **Time horizon:** 3-5 years to IV-base; longer if regime change in regulation or rates is required.
- **Key monitor metrics:** quarterly NCOs in CRE, deposit beta, CET1 ratio trajectory, Elavon fee-revenue growth, ROTCE recovery toward 17%.